Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Evidence-Based Complementary and Alternative Medicine, enter your email address in the box below.

Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 4082630, 7 pages
https://doi.org/10.1155/2017/4082630
Research Article

Use of Chinese Medicine Reduces the Development of Cervical Cancer from Pap Smear-Diagnosed Cervical Dysplasia: A Case-Control Study

Li-Ling Shen,1 Chih-Hsin Muo,2,3 Shan-Yu Su,1,4 and Donald E. Morisky5

1Department of Chinese Medicine, China Medical University Hospital, Taichung 40447, Taiwan
2Department of Public Health, China Medical University, Taichung 40402, Taiwan
3Management Office for Health Data, China Medical University Hospital, Taichung 40402, Taiwan
4School of Post-Baccalaureate Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung 40402, Taiwan
5Department of Community Health Sciences, UCLA Fielding School of Public Health, Los Angeles, CA 90095-1772, USA

Correspondence should be addressed to Shan-Yu Su; moc.liamg@usuynahs

Received 5 September 2017; Accepted 2 November 2017; Published 31 December 2017

Academic Editor: Kenji Watanabe

Copyright © 2017 Li-Ling Shen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Frumovitz, Invasive cervical cancer: Epidemiology, risk factors, clinical manifestations, and diagnosis, 2015.
  2. M. Quinn et al., “Effect of screening on incidence of and mortality from cancer of cervix in england: Evaluation based on routinely collected statistics,” British Medical Journal, vol. 318, no. 7188, pp. 904–908, 1999. View at Google Scholar
  3. M.-C. Hung, M.-T. Liu, Y.-M. Cheng, and J.-D. Wang, “Estimation of savings of life-years and cost from early detection of cervical cancer: A follow-up study using nationwide databases for the period 2002-2009,” BMC Cancer, vol. 14, no. 1, article no. 505, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. Y.-Y. Chen, S.-L. You, S.-L. Koong, J. Liu, C.-A. Chen, and C.-J. Chen, “Screening frequency and atypical cells and the prediction of cervical cancer risk,” Obstetrics & Gynecology, vol. 123, no. 5, pp. 1003–1011, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. A. G. ÖStör, “Natural history of cervical intraepithelial Neoplasia: A critical review,” International Journal of Gynecological Pathology, vol. 12, no. 2, pp. 186–192, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Saslow et al., “American cancer society guideline for the early detection of cervical neoplasia and cancer,” CA: A Cancer Journal for Clinicians, vol. 52, no. 6, pp. 342–362, 2002. View at Google Scholar
  7. E. Paraskevaidis, M. Arbyn, A. Sotiriadis et al., “The role of HPV DNA testing in the follow-up period after treatment for CIN: A systematic review of the literature,” Cancer Treatment Reviews, vol. 30, no. 2, pp. 205–211, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. C. E. M. C. Andrade, C. Scapulatempo-Neto, A. Longatto-Filho et al., “Prognostic scores after surgical treatment for cervical intraepithelial neoplasia: A proposed model and possible implications for post-operative follow-up,” Acta Obstetricia et Gynecologica Scandinavica, vol. 93, no. 9, pp. 941–948, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Li, J. Wang, F. Lin, Y. Yang, and S.-S. Chen, “A methodology for cancer therapeutics by systems pharmacology-based analysis: A case study on breast cancer-related traditional Chinese medicines,” PLoS ONE, vol. 12, no. 1, Article ID e0169363, 2017. View at Publisher · View at Google Scholar · View at Scopus
  10. W.-P. Deng, M.-W. Chao, W.-F. Lai et al., “Correction of malignant behavior of tumor cells by traditional Chinese herb medicine through a restoration of p53,” Cancer Letters, vol. 233, no. 2, pp. 315–327, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Y. Wu et al., “Anti-cancer effect of danshen and dihydroisotanshinone i on prostate cancer: Targeting the crosstalk between macrophages and cancer cells via inhibition of the stat3/ccl2 signaling pathway,” Oncotarget, vol. 8, 2017. View at Google Scholar
  12. M. J. Montbriand, “Herbs or natural products that protect against cancer growth part three of a four-part series,” Oncology Nursing Forum, vol. 31, no. 6, pp. E127–E146, 2004. View at Google Scholar
  13. B. Hu, H.-M. An, S.-S. Wang, J.-J. Chen, and L. Xu, “Preventive and therapeutic effects of Chinese herbal compounds against hepatocellular carcinoma,” Molecules, vol. 21, no. 2, article no. 142, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Kocaadam and N. Şanlier, “Curcumin, an active component of turmeric (curcuma longa), and its effects on health,” Critical Reviews in Food Science and Nutrition, vol. 57, no. 13, pp. 2889–2895, 2015. View at Publisher · View at Google Scholar
  15. Y.-C. Hu, C.-T. Wu, J.-N. Lai, and Y.-T. Tsai, “Detection of a negative correlation between prescription of Chinese herbal products containing coumestrol, genistein or daidzein and risk of subsequent endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan between 1998 and 2008: A population-based study,” Journal of Ethnopharmacology, vol. 169, pp. 356–362, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. M.-S. Jong, S.-J. Hwang, Y.-C. Chen, T.-J. Chen, F.-J. Chen, and F.-P. Chen, “Prescriptions of chinese herbal medicine for constipation under the National Health Insurance in Taiwan,” Journal of the Chinese Medical Association, vol. 73, no. 7, pp. 375–383, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Y. Chiang et al., “The impact of national health insurance on the notification of tuberculosis in taiwan,” The International Journal of Tuberculosis and Lung Disease, vol. 6, no. 11, pp. 974–979, 2002. View at Google Scholar
  18. D. Gamus, “Advances in research of complementary and integrative medicine: A review of recent publications in some of the leading medical journals,” Harefuah, vol. 154, no. 1, pp. 9–15, 70, 2015. View at Google Scholar
  19. S. Zhuang, S. Chen, J. Tsai et al., “Effect of citronellol and the Chinese medical herb complex on cellular immunity of cancer patients receiving chemotherapy/radiotherapy,” Phytotherapy Research, vol. 23, no. 6, pp. 785–790, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Menvielle, J. Dugas, J.-B. Richard, and D. Luce, “Socioeconomic and healthcare use-related determinants of cervical, breast and colorectal cancer screening practice in the French West Indies,” European Journal of Cancer Prevention, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Shrimali, M. K. Shanmugam, A. P. Kumar et al., “Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer,” Cancer Letters, vol. 341, no. 2, pp. 139–149, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Wang, H. Z. Yu, Y. Zhang, Y. Liu, X. Ge, and X. Wu, “Emodin induces apoptosis of human cervical cancer hela cells via intrinsic mitochondrial and extrinsic death receptor pathway,” Cancer Cell International, vol. 13, no. 1, article 71, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Gao, W. Sun, J. Zhao et al., “Tanshinones and diethyl blechnics with anti-inflammatory and anti-cancer activities from salvia miltiorrhiza bunge (danshen),” Scientific Reports, vol. 6, Article ID 33720, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Munagala, F. Aqil, J. Jeyabalan, and R. C. Gupta, “Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer,” Cancer Letters, vol. 356, no. 2, pp. 536–546, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. Y.-C. Hung, T.-L. Pan, and W.-L. Hu, “Roles of Reactive Oxygen Species in Anticancer Therapy with Salvia miltiorrhiza Bunge,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 5293284, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Zhao et al., “Cytotoxicity enhancement in mda-mb-231 cells by the combination treatment of tetrahydropalmatine and berberine derived from corydalis yanhusuo w. T. Wang,” Journal of Intercultural Ethnopharmacology, vol. 3, no. 2, pp. 68–72, 2014. View at Google Scholar
  27. X. Wu, Z. Yang, H. Dang, H. Peng, and Z. Dai, “Baicalein inhibits the proliferation of cervical cancer cells through the GSK3ß-dependent pathway,” Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 2017. View at Publisher · View at Google Scholar
  28. Y. Ma, H. Han, J. S. Eun, H.-C. Kim, J.-T. Hong, and K.-W. Oh, “Sanjoinine A isolated from Zizyphi Spinosi Semen augments pentobarbital-induced sleeping behaviors through the modification of GABA-ergic systems,” Biological & Pharmaceutical Bulletin, vol. 30, no. 9, pp. 1748–1753, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. T. C. Erren, H. G. Pape, R. J. Reiter, and C. Piekarski, “Chronodisruption and cancer,” Naturwissenschaften, vol. 95, no. 5, pp. 367–382, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. Y.-H. Liao, C.-C. Lin, H.-C. Lai, J.-H. Chiang, J.-G. Lin, and T.-C. Li, “Adjunctive traditional Chinese medicine therapy improves survival of liver cancer patients,” Liver International, vol. 35, no. 12, pp. 2595–2602, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Hidaka, R. Yonezawa, and S. Saito, “Kami-shoyo-san, Kampo (Japanese traditional medicine), is effective for climacteric syndrome, especially in hormone-replacement-therapy-resistant patients who strongly complain of psychological symptoms,” Journal of Obstetrics and Gynaecology Research, vol. 39, no. 1, pp. 223–228, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Terauchi, S. Hiramitsu, M. Akiyoshi et al., “Effects of three Kampo formulae: Tokishakuyakusan (TJ-23), Kamishoyosan (TJ-24), and Keishibukuryogan (TJ-25) on Japanese peri- and postmenopausal women with sleep disturbances,” Archives of Gynecology and Obstetrics, vol. 284, no. 4, pp. 913–921, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. J. B. Jeong, S. Y. Ju, J. H. Park et al., “Antioxidant activity in essential oils of Cnidium officinale makino and Ligusticum chuanxiong hort and their inhibitory effects on DNA damage and apoptosis induced by ultraviolet B in mammalian cell,” Cancer Epidemiology, vol. 33, no. 1, pp. 41–46, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Chen, H. Chen, Y. Wang, and J. Zhang, “In vitro and in vivo antitumour activities of puerarin 6″-O-xyloside on human lung carcinoma A549 cell line via the induction of the mitochondria-mediated apoptosis pathway,” Pharmaceutical Biology, vol. 54, no. 9, pp. 1793–1799, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. W. G. Zhang et al., “Puerarin induces hepatocellular carcinoma cell apoptosis modulated by mapk signaling pathways in a dose-dependent manner,” Anticancer Reseach, vol. 37, no. 8, pp. 4425–4431, 2017. View at Google Scholar
  36. L. W. Freeman, Complementary and Alternative Medicine: A Research-Based Approach, Elsevier, London, UK, 2009.
  37. E. Roura et al., “The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: Results from the epic cohort,” PLoS ONE, vol. 11, no. 1, p. e0147029, 2016. View at Google Scholar